• Non ci sono risultati.

Barnes J, Anderson LA, Gibbons S, Philipson JD. Echinacea species(Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties.

N/A
N/A
Protected

Academic year: 2021

Condividi "Barnes J, Anderson LA, Gibbons S, Philipson JD. Echinacea species(Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties."

Copied!
3
0
0

Testo completo

(1)

93 Barnes J, Anderson LA, Gibbons S, Philipson JD. Echinacea species(Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties. The Journal of Pharmacy and Pharmacology, 2005, 57:929-954.

Barret B. Medicinal properties of Echinacea: A critical review. Phytomedicine, 2003, 10:66-86.

Bauer R, Wagner H. Echinacea species as potential immunostimulatory drugs. Economic and Medicinal Plant Research, 1991, 5:253-321.

Bauer R. Plant immunostimulants in self-medication. Pharm Unserer Zeit, 1998, 27:144-157.

Bruni A. Farmacognosia generale e applicata. Ed. Piccin Nuova Libreria S.p.A., 1999, 12:314-315.

Burger RA, Torres AR, Warren RP, Caldwell VD, Hughes BG. Echinacea-induced cytokine production by human macrophages. Int J Immunopharmacol, 1997, 19:371-379.

Capasso F, Bonelli F, Longo R, Capasso R. Farmacognosia applicata: controllo di qualità delle droghe vegetali. Ed.Springer, 2007, 50.

Capasso F, De Pasquale R, Grandolini G, Mascolo N. Farmacognosia:Farmaci naturali, loro preparazioni ed impiego terapeutico. Ed. Springer, 2000, 357-360.

Capasso F, Grandolini G, Izzo AA, Fitoterapia: impiego razionale delle droghe vegetali. Ed. Springer, 2006, 617.

Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Current Opinion in Immunology, 1997, 9:10-16.

Chaput N, Taieb J, Schartz NE, Andre F, Angevin E, Zitvogel L. Exosome-based immunotherapy. Cancer Immunol Immunother., 2004, 53:234-239.

Chicca A, Adinolfi B, Martinotti E, Fogli S, Breschi MC, Pellati F, Benvenuti S, Nieri P. Cytotoxic effects of Echinacea root hexanic extracts on human cancer cell lines. J Ethnopharmacol, 2007, 110:148-53.

(2)

94 Di Nicola M, Lemoli RM. Dendritic cells: specialized antigen presentino cells. Haematologica, 2000, 85:202-207.

Feili-Hariri M, Falkner DH, Morel PA. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations:implications for immunotherapy. Journal of Leukocyte Biology, 2005, 78:656-664

Krug LM. Vaccine therapy for small cell lung cancer. Semin Oncol., 2004, 31:112-116.

Lanzavecchia A. Mechanism of antigen uptake for presentation. Current opinion in Immunology, 1996, 8:348-354

Liu Y, Murphy PA. Alkamide stability in Echinacea purpurea extract with and without phenolic acids in dry films and in solution. J. Agric. Food Chem., 2007, 55(1):120-126.

Luettig B, Steinmuller C, Gifford GE, Wagner H Lohmann ML. Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea. J Natl Cancer Inst, 1989, 81:669-675.

Mishima S, Saito K, Maruyama H, Inoue M, Yamashita T, Ishida T, Gu Y. Antioxidant and Immuno-Enhancing Effects of Echinacea purpurea. Biol. Pharm. Bull., 2004, 27(7):1004-1009.

Percival SS. Use of Echinacea in medicine. Biochemical Pharmacology, 2000, vol 60: 155-158

Rininger JA, Kickner S, Chigurupati P, McLean A, Franck Z. Immunopharmacological activity of Echinacea preparations following simulated digestion on murine macrophages and human peripheral blood mononuclear cells. J Leukoc Biol, 2000, 68:503-510.

Speroni E, Covoni P, Guizzardi S, Renzulli C, Guerra MC. Anti-inflammatory and cicatrizing activity of Echinacea pallida Nutt root extract. J. Ethnopharmacol., 2002, 79:265-272.

Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature, 2007, vol 449:419-426 (reviews)

Steinman RM. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol, 1991, 9:271-296.

(3)

95 Stockwin LH, McGonagle D, Martin IG, Blair GE. Dendritic cells: Immunological sentinels with a central role in health and disease. Immunology and Cell Biology, 2000, 78:91-102.(review article).

Theofilopoulos AN, Koundouris S, Kono DH, LawsonBR. The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity. Arthritis Res., 2001, 3(3):136.

Tragni E, Galli CL, Tubaro A, Del Negro P, Della Loggia R. Anti-infiammatory activity of E. angustifolia fraction separated on the basis of molecolar weight. Pharmacol. Res. Commun., 1988, 20:87-90.

Wang CY, Chiao MT, Yen PJ, Huang WC, Hou CC, Chien SC, Yeh KC, Yang WC, Shyur LF, Yang NS. Modulatory effects of Echinacea purpurea extracts on human dendritic cells: a cell- and gene-based study. Genomics, 2006, 88:801-808.

Riferimenti

Documenti correlati

European Commission (2020b) - Communication from the Commission to the European Parliament, the Council, the European Economic and Social Commit- tee and the Committee of the

Nella città dell'estrema «fusione e confusione», è ancora una volta – come nel capolavoro di Phillips, La memoria del sangue – l'archetipo di Otello a venire scomodato per

y to analyze the key labour market determinants of migration flows from selected Arab Mediterranean Countries (Algeria, Egypt, Jordan, Lebanon, Morocco, Syria, Tunisia and the

In our model the excess IR luminosity could be explained by accretion on a central hole, when the accretion rate is small enough for the accreting gas to be essentially

Since Stf76 ex- hibits a high degree of structural similarity to the OhrR wHTH domain, as shown by the DALI analysis, we used the structure of the OhrR-wHTH in complex with its

The goal of our methodology is to model the relationship between business and technical performance of a specific use case. Ultimately, the goal is the selection of the

As far as economic issues are concerned, the analysis has shown that Delta and Etihad do not focus primarily on the economic aspect of their performance, but rather on